Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 9c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.26), $0.09 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c